Scientific Journal of KubSAU

The authors made an analysis of biotechnology firms, working in medicine. In terms of the current direction of Russian economy in the process of import substitution, the researched topic of this article has its urgency based on understanding that to build competitive industries in the Russian Federation it is necessary to examine and adjust experience of leading states with certain achievements in pharmacology. Implementation of industry development programmes is possible not only through the active participation by state administration, but also through understanding of how overseas market participants operate. Thus, the object of research is companies of the biotechnology industry, the subject of the research are the financial indicators in relation to industrial value chain strategies. The United States market data was used because of the availability of substantial sources of information that are easier in intelligence conduction, and also due to the fact that the experience of the developed market economy can serve as a model for understanding the work of the business and its patterns for domestic entrepreneurs and public servants. Based on analysis made with descriptive statistics and econometric tools the authors demonstrated the correlation between financial performance and strategy of the value chain